Safety and Tolerability of LX101 for Inherited Retinal Dystrophy Associated With RPE65 Mutations

NCT06196827 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

9

Enrollment

INDUSTRY

Sponsor class

Conditions

Inherited Retinal Dystrophy Associated With RPE65 Mutations

Interventions

GENETIC: LX101

Sponsor

Innostellar Biotherapeutics Co.,Ltd